The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil-Reference-Cited by-同舟云学术

The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil

Published:2021-01-28 Issue:4 Volume:19 Page:557-577
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

da Silva Wânia Cristina^ORCID,Godman Brian^ORCID,de Assis Acúrcio Francisco^ORCID,Cherchiglia Mariângela Leal^ORCID,Martin Antony^ORCID,Maruszczyk Konrad,Izidoro Jans Bastos,Portella Marcos André,Lana Agner Pereira,Campos Neto Orozimbo Henriques^ORCID,Andrade Eli Iola Gurgel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40258-020-00626-0.pdf

Reference88 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68(6):394–424.

2. Silva ACB, Vicentini MFB, Mendoza EZ, Fujiki FK, da Fonseca LG, Braghiroli M, et al. Young-age onset colorectal cancer in Brazil: analysis of incidence, clinical features, and outcomes in a tertiary cancer center. Curr Probl Cancer. 2019;43(5):477–86.

3. Souza DL, Jerez-Roig J, Cabral FJ, de Lima JR, Rutalira MK, Costa JA. Colorectal cancer mortality in Brazil: predictions until the year 2025 and cancer control implications. Dis Colon Rectum. 2014;57(9):1082–9.

4. Guerra MR, Bustamante-Teixeira MT, Corrêa CSL, Abreu DMXd, Curado MP, Mooney M, et al. Magnitude and variation of the burden of cancer mortality in Brazil and Federation Units, 1990 and 2015. Rev Bras Epidemiol. 2017;20(Suppl 01):102–15.

5. Silva DAS, Tremblay MS, Souza MdFMd, Mooney M, Naghavi M, Malta DC. Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990–2015): Findings from the Global Burden of Disease Study. PloS One. 2018;13(2):e0190943-e.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study;Frontiers in Public Health;2021-11-05

2. Budget impact of monoclonal antibodies for metastatic colorectal cancer substantial in Brazil;PharmacoEconomics & Outcomes News;2021-02